Table 1.
Baseline demographic and clinical characteristics of patients n (%)
| Total (n = 68) | |
| Age (yr) | 64.9 (38-89) |
| Male/female | 48 (70.6)/20 (29.4) |
| BMI (kg/m2) | 22.9 (17.7-31.9) |
| Previous IA surgery | 19 (27.9) |
| Laboratory findings | |
| Hemoglobin (g/dL) | 12.4 (7.2-17.3) |
| White blood cells (/mm3) | 8471.7 (3050-19850) |
| Albumin (g/dL) | 3.8 (2.5-5.2) |
| ASA classification | |
| 1 | 11 (16.2) |
| 2 | 50 (73.5) |
| 3 | 7 (10.3) |
| TNM Stage of tumor | |
| II | 22 (32.4) |
| III | 26 (38.2) |
| IVA | 20 (29.4) |
| Histology | |
| WD | 8 (11.8) |
| MD | 57 (83.8) |
| PD | 3 (5.6) |
| Location of obstruction | |
| Sigmoid flexure | 5 (7.4) |
| Descending colon | 7 (10.3) |
| Sigmoid-descending area | 9 (13.2) |
| Sigmoid colon | 22 (32.4) |
| Recto-sigmoid area | 25 (36.8) |
BMI: Body mass index; IA: Intra-abdominal; ASA: American society of anesthesiologists; WD: Well-differentiated cancer; MD: Moderate-differentiated cancer; PD: Poorly-differentiated cancer.